Lupin gets USFDA approval to market its postherpetic neuralgia drug Ruby Khatun Khatun29 Aug 2018 1:43 PM ISTLupin has received final approval to market its Gabapentin tablets USP in the strengths of 600 mg and 800 mg from USFDA for postherpetic neuralgiaNew...
Health ministry calls for halting sales of e-cigarettes, smoking devices Ruby Khatun Khatun29 Aug 2018 10:15 AM ISTNew Delhi: Health Ministry called for stopping the sale or import of electronic cigarettes and heat-not-burn tobacco devices that companies like...
India, EU join hands to develop new Influenza vaccine Ruby Khatun Khatun29 Aug 2018 10:15 AM ISTNew Delhi: The Indian government and the European Union (EU), joined hands for Rs. 240 crore research programme to develop a Next Generation Influenza...
USFDA approves Tetraphase Pharma's antibiotic Ruby Khatun Khatun29 Aug 2018 9:45 AM ISTThe U. S. Food and Drug Administration approved Tetraphase Pharmaceuticals Inc's antibiotic for complicated intra-abdominal infections, providing a...
Pfizer rare heart disease drug reduces risk of death by 30 percent in study Ruby Khatun Khatun29 Aug 2018 9:30 AM ISTNEW YORK: Pfizer Inc said that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent,...
Lupin launches contraceptive drug in US Ruby Khatun Khatun28 Aug 2018 11:00 AM ISTNew Delhi: Drug maker Lupin launched Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets and Levomefolate Calcium tablets, used to prevent...
Abbott India lines up 100 product launches over the next 5 years Ruby Khatun Khatun28 Aug 2018 10:30 AM ISTNew Delhi: Drug major Abbott India Ltd aims to launch around 100 products over the next five years as it looks to strengthen existing therapy areas as...
Novartis's Kymriah wins EU approval for blood cancer treatment Ruby Khatun Khatun28 Aug 2018 10:00 AM ISTZURICH: Swiss drugmaker Novartis received European Commission approval for Kymriah, its CAR-T cell therapy, to treat children with a form of leukemia...
Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 9:45 AM ISTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
FDA declines to approve Akcea-Ionis genetic disease drug Ruby Khatun Khatun28 Aug 2018 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) declined to approve a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals that aims to treat a...
Fortis, RHT extend last date for completing acquisition Ruby Khatun Khatun27 Aug 2018 11:53 AM ISTNew Delhi: Fortis Healthcare Ltd and RHT Health Trust have agreed to extend the last date for the acquisition of an entire portfolio of assets of the...
Lupin enters prescription dermatology segment in Brazil Ruby Khatun Khatun27 Aug 2018 10:15 AM ISTNew Delhi: Drug maker Lupin said it has entered the prescription dermatology segment in Brazil with the launch of two products Fillerina and Recrexina...
